Myocytes Die by Multiple Mechanisms in Failing Human Hearts

&NA; We tested the hypothesis that myocyte loss in failing human hearts occurs by different mechanisms: apoptosis, oncosis, and autophagic cell death. Explanted hearts from 19 patients with idiopathic dilated cardiomyopathy (EF≤20%) and 7 control hearts were analyzed. Myocyte apoptosis revealed by caspase‐3 activation and TUNEL staining occurred at a rate of 0.002±0.0005% (P<0.05 versus control) and oncosis assessed by complement 9 labeling at 0.06±0.001% (P<0.05). Cellular degeneration including appearance of ubiquitin containing autophagic vacuoles and nuclear disintegration was present at the ultrastructural level. Nuclear and cytosolic ubiquitin/protein accumulations occurred at 0.08±0.004% (P<0.05). The ubiquitin‐activating enzyme E1 and the ligase E3 were not different from control. In contrast, ubiquitin mRNA levels were 1.8‐fold (P<0.02) elevated, and the conjugating enzyme E2 was 2.3‐fold upregulated (P<0.005). The most important finding, however, is the 2.3‐fold downregulation of the deubiquitination enzyme isopeptidase‐T and the 1.5‐fold reduction of the ubiquitin‐fusion degradation system‐1, which in conjunction with unchanged proteasomal subunit levels and proteasomal activity results in massive storage of ubiquitin/protein complexes and in autophagic cell death. A 2‐fold decrease of cathepsin D might be an additional factor responsible for the accumulation of ubiquitin/protein conjugates. It is concluded that in human failing hearts apoptosis, oncosis, and autophagy act in parallel to varying degrees. A disturbed balance between a high rate of ubiquitination and inadequate degradation of ubiquitin/protein conjugates may contribute to autophagic cell death. Together, these different types of cell death play a significant role for myocyte disappearance and the development of contractile dysfunction in failing hearts. (Circ Res. 2003;92:715–724.)

[1]  A. Meijer,et al.  UvA-DARE ( Digital Academic Repository ) Autophagic proteolysis : control and specificity , 1997 .

[2]  N. Rose,et al.  Cardiomyopathy is linked to complement activation. , 2002, The American journal of pathology.

[3]  P. D. de Tombe,et al.  Functional consequences of caspase activation in cardiac myocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[5]  L. Greene,et al.  Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death , 2001, The Journal of Neuroscience.

[6]  M J Davies,et al.  Apoptotic versus autophagic cell death in heart failure. , 2001, Cardiovascular research.

[7]  E. Arbustini,et al.  Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes. , 2001, Cardiology clinics.

[8]  R. Kopito,et al.  Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.

[9]  S. Emr,et al.  Autophagy as a regulated pathway of cellular degradation. , 2000, Science.

[10]  E. Barrett,et al.  The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes. , 2000, Biochemical and biophysical research communications.

[11]  A. Varshavsky,et al.  Detecting and measuring cotranslational protein degradation in vivo. , 2000, Science.

[12]  C. Pickart,et al.  Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Dimauro,et al.  Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) , 2000, Nature.

[14]  W. Schaper,et al.  Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. , 2000, Circulation research.

[15]  W. Bursch,et al.  Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments. , 2000, Journal of cell science.

[16]  A. Ciechanover,et al.  The ubiquitin‐mediated proteolytic pathway: Mode of action and clinical implications , 2000, Journal of cellular biochemistry. Supplement.

[17]  B. Osborne,et al.  Cell death in the third millennium , 2000, Cell Death and Differentiation.

[18]  K. Jellinger Cell death mechanisms in Parkinson's disease , 2000, Journal of Neural Transmission.

[19]  K. Jellinger,et al.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. , 1999, The American journal of pathology.

[20]  J. Schaper,et al.  The role of cell death in heart failure. , 1999, Circulation research.

[21]  Yoshiyuki Kuchino,et al.  Caspase-independent programmed cell death with necrotic morphology , 1999, Cell Death and Differentiation.

[22]  A. Samarel,et al.  Sarcomeric myosin heavy chain is degraded by the proteasome , 1999, Cell and Tissue Research.

[23]  T. Aoyama,et al.  Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. , 1999, Circulation.

[24]  M. Figueiredo-Pereira,et al.  Ubiquitin, cellular inclusions and their role in neurodegeneration , 1998, Trends in Neurosciences.

[25]  G. Takemura,et al.  "Apoptotic" myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with In situ nick end-labeling. , 1998, Circulation.

[26]  P. Anversa,et al.  Myocyte death and growth in the failing heart. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[27]  A. Howie,et al.  High prevalence of acute myocardial damage in a hospital necropsy series, shown by C9 immunohistology. , 1998, Journal of clinical pathology.

[28]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[29]  J. Schaper,et al.  Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. , 1997, European heart journal.

[30]  Y. Agid,et al.  Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. , 1997, Histology and histopathology.

[31]  R. Frank,et al.  Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. , 1996, The New England journal of medicine.

[32]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[33]  J. Townend,et al.  Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections. , 1996, Journal of clinical pathology.

[34]  P. Anversa,et al.  Gender differences and aging: effects on the human heart. , 1995, Journal of the American College of Cardiology.

[35]  I. Ota,et al.  A Proteolytic Pathway That Recognizes Ubiquitin as a Degradation Signal (*) , 1995, The Journal of Biological Chemistry.

[36]  L. Schwartz,et al.  Coordinated Induction of the Ubiquitin Conjugation Pathway Accompanies the Developmentally Programmed Death of Insect Skeletal Muscle (*) , 1995, The Journal of Biological Chemistry.

[37]  H. Elsässer,et al.  Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. , 1995, European journal of cell biology.

[38]  G. Majno,et al.  Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.

[39]  A. Hershko,et al.  A ubiquitin C-terminal isopeptidase that acts on polyubiquitin chains. Role in protein degradation. , 1992, The Journal of biological chemistry.

[40]  A. Friedl,et al.  Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. , 1991, Circulation.

[41]  R. Jennings,et al.  Comparison of the effect of ischaemia and anoxia on the sarcolemma of the dog heart. , 1983, European heart journal.

[42]  F. Kaindl,et al.  How valuable is scintigraphy during rest? , 1983, European heart journal.